ClinConnect ClinConnect Logo
Search / Trial NCT05483296

Effects of Afternoon and Evening Light on Teenagers' Melatonin Levels, Alertness, Sleepiness and Sleep

Launched by UNIVERSITY PSYCHIATRIC CLINICS BASEL · Jul 31, 2022

Trial Information

Current as of May 25, 2025

Completed

Keywords

Melatonin Polysomnography Eeg Sleep Afternoon Light Pupil Size Evening Light

ClinConnect Summary

Light exposure during adolescence seems to be the critical component of a vicious circle. Due to the maturation of sleep-wake regulatory systems in combination with progressively ill-timed exposure to light and early school start times, teenagers suffer from the accumulation of sleep depth during school days. Therefore, the proposed study investigates whether the physiological and alerting effects of late evening light exposure in adolescents depend on the intensity of light exposure in the preceding afternoon (primary endpoint: evening melatonin concentration).

The investigators aim to de...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy
  • Capable of judgment
  • Normal BMI (Age-related Body-Mass-Index Percentile \> P3 \& \< P97; approx. corresponding to 28.5 ≥ BMI ≤ 16)
  • Signed consent form of participants
  • Signed consent form of a legal representative
  • Exclusion Criteria:
  • Pregnancy or breastfeeding (only female)
  • Current participation in other clinical trials
  • Extreme chronotype (Extreme early or late chronotype/mid sleep time: mid-sleep time \< 1:00 / \> 7:00)
  • Extremely short or long sleep durations during school- or work days (\< 6 hours \> 11 hours)
  • Sleep disorders
  • High myopia (\< -6 diopters)
  • High hyperopia (\> +6 diopters)
  • Non-normal best-corrected visual acuity (BCVA \< 0.5 \[20/40\])
  • General health concerns or disorders, including heart and cardiovascular, neurological, nephrological, endocrinological, and psychiatric conditions
  • Ophthalmological or optometric conditions
  • Medication impacting visual, neuroendocrine, sleep, and circadian physiology
  • Drug and alcohol use (urinary drug screening \& breathalyzer test)
  • Non-compliance with sleep-wake times: \>1 deviation from ±60 minute window sleep and wake-up time
  • Non-compliance with caffeine intake (\> 1 times caffeine intake)
  • Transmeridian travel (\>2 time zones) \<1 month prior to the first session of the study
  • shift work \<3 months prior to the beginning of the study

About University Psychiatric Clinics Basel

The University Psychiatric Clinics Basel is a leading institution dedicated to advancing mental health care through innovative research and clinical practice. Affiliated with the University of Basel, this esteemed center specializes in psychiatric and psychological treatment, offering a comprehensive range of services for various mental health conditions. With a strong emphasis on clinical trials, the clinics engage in cutting-edge research to evaluate new therapies and improve existing treatment protocols, fostering collaboration between academia and clinical practice. Their commitment to excellence in patient care, education, and research contributes to significant advancements in the field of psychiatry, ultimately enhancing the quality of life for individuals affected by mental health disorders.

Locations

Basel, Canton Of Basel City, Switzerland

Patients applied

0 patients applied

Trial Officials

Christian Cajochen, PhD

Principal Investigator

Centre for Chronobiology, University Psychiatric Clinics Basel, Basel, Switzerland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials